Ubiquitin‐specific protease 22 (USP22) stabilizes SIRT1 and activates the PI3K/Akt/mTOR pathway through enhancing SIRT1‐mediated PTEN deacetylation, thereby promoting melanoma metastasis both in vitro and in vivo. Here, USP22 is linked to melanoma.